Schedule 13D ownership disclosure
Zenas Biopharma Inc
Common Stock, par value $0.0001 per share · CUSIP: 98937L105
Event date: 2025-10-09
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Enavate Sciences GP, LLCReported CIK 0001953107
Shares: 3,919,159.00 · Class: 7.3%
- Zebra Aggregator, LPReported CIK 0002037042
Shares: 3,919,159.00 · Class: 7.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001953107-25-000010
- Form type
- SCHEDULE 13D/A
- Filer
- Enavate Sciences GP, LLC
- CIK
- CIK 1953107
- Filed
- Oct 14, 2025
- Reporting period
- Oct 09, 2025
- Description
- Schedule 13D beneficial ownership